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Background: LRP6 is an essential co-receptor 
for Wnt/β-catenin signaling, which controls 
various biological pathways. 
Results: LRP6 tyrosine mutant exhibited longer 
half-life and increased lipid raft distribution, 
phosphorylation, and signaling.     
Conclusion: Clathrin-mediated endocytosis of 
LRP6 mediates its degradation, while 
caveolae-dependent pathway promotes 
Wnt/β-catenin signaling. 
Significance: Understanding the molecular 
mechanisms underlying LRP6 endocytosis and 
Wnt/β-catenin signaling will help the 
development of therapeutic methods targeting 
this pathway.  
 
SUMMARY  
Wnt/β-catenin signaling orchestrates a 
number of critical events including cell 
growth, differentiation and cell survival 
during development. Misregulation of this 
pathway leads to various human diseases, 
specifically cancers. Endocytosis and 
phosphorylation of the LDL receptor-related 
protein 6 (LRP6), an essential co-receptor for 
Wnt/β-catenin signaling, play a vital role in 
mediating Wnt/β-catenin signal transduction. 
However, its regulatory mechanism is not 
fully understood. In this study, we define the 
mechanisms by which LRP6 endocytic 
trafficking regulates Wnt/β-catenin signaling 
activation. We show that LRP6 mutant with 
defective tyrosine-based signal in its 
cytoplasmic tail has an increased cell surface 
distribution and decreased endocytosis rate. 
These changes in LRP6 endocytosis coincide 
with an increased distribution to caveolae, 
increased phosphorylation, and enhanced 
Wnt/β-catenin signaling. We further 
demonstrate that treatment of Wnt3a ligands 
or blocking the clathrin-mediated endocytosis 
of LRP6 lead to a redistribution of wild-type 
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receptor to lipid rafts. The LRP6 tyrosine 
mutant also exhibited an increase in signaling 
activation in response to Wnt3a stimulation 
compared to wild-type LRP6, and this 
activation is suppressed when 
caveolae-mediated endocytosis is blocked. 
Our results reveal molecular mechanisms by 
which LRP6 endocytosis routes regulate its 
phosphorylation and the strength of 
Wnt/β-catenin signaling, and have 
implications on how this pathway can be 
modulated in human diseases. 
 
    The Wnt/β-catenin signaling pathway 
regulates various events during embryonic 
development, including cell proliferation, 
survival, migration and polarity, specification of 
cell fate, and self-renewal (1-3). As such, 
abnormal Wnt/β-catenin signaling leads to 
defects in embryonic development as well as a 
variety of human diseases, such as cancer (4) 
and Alzheimer’s disease (5). The Wnt family 
consist of 19 secreted glycoproteins (6) that 
engage two cell surface receptors - the Frizzled 
(Fz) family (7) and low-density lipoprotein 
receptor (LDLR)-related protein 5/6 (LRP5/6) 
(8). Wnt-stimulation induces the 
phosphorylation of LRP5/6, which leads to a 
suppression of glycogen synthase kinase 3β 
(GSK3β)-mediated β-catenin phosphorylation 
(9,10). Consequently, β-catenin accumulates and 
translocates to the nucleus, where it activates 
target gene expression (1,11).  
      Endocytosis of cell-surface receptors is 
an important regulatory event in signal 
transduction including Wnt/β-catenin signaling 
(12,13). Studies show that the clathrin-mediated 
pathway plays a crucial role in terminating cell 
signaling by down-regulating transmembrane 
signaling receptors (14,15). In some cases when 
signaling is constitutively active, however, 
receptors may undergo continuous rounds of 
endocytosis and recycling, thus protecting the 
receptors from degradation (16-18). 
Clathrin-independent internalization occurs 
mostly at lipid rafts, which are membrane 
microdomains that consist of a dynamic 
assembly of cholesterol and glycosphingolipids 
(19). Caveolin mediates some of the 
clathrin-independent events, forming membrane 
invaginations caveolae on lipid rafts (20). This 
pathway has been shown to function as a 
platform for receptor-mediated signaling by 
facilitating the sequestration of receptors and 
signaling molecules within caveolae (21,22). 
Cell surface receptors that traffic between the 
plasma membrane and endocytic compartments 
contain signals within their cytoplasmic tails that 
enable their efficient recruitment into endocytic 
vesicles. Several classes of endocytosis signals 
have been identified that target surface proteins 
to clathrin-coated vesicles (23). Tyrosine-based 
motifs NPXY or YXXØ (where X can be any 
amino acid and Ø is an amino acid with a bulky 
hydrophobic group) within the cytoplasmic tail 
were initially identified in the LDLR and 
transferrin receptors (24). In addition, 
ligand-induced phosphorylation of serine 
residues can also serve as a signal for receptor 
endocytosis, noticeably for members of the G 
protein-coupled receptor family (25). 
LRP6 contains multiple potential 
endocytosis motifs within its cytoplasmic region, 
including two tyrosine-based signals and five 
conserved PPP(S/T)P motifs, whose 
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signaling (10).  Therefore, we hypothesize that 
specific sequence motifs in the intracellular 
domain of LRP6 regulate its endocytosis and 
signal transduction. Here we defined the 
mechanisms underlying LRP6 endocytosis, 
phosphorylation and Wnt/β-catenin signaling 
using unique LRP6 mutants.  
 
EXPERIMENTAL PROCEDURES 
Cloning of LRP6 wild-type and mutants - 
LRP6 mutations were generated by site-directed 
mutagenesis using QuickChange mutagenesis kit 
(Stratagene), according to the manufacturer’s 
instructions. All constructs were verified by 
sequencing. LRP6 WT and mutants, each of 
which contains a HA tag at its N-terminus, were 
then subcloned into Flp-In expression vectors 
(Invitrogen). Upon recombinase-mediated DNA 
recombination, LRP6 was integrated into the 
genome at a specific location. 
Cell culture and reagent - Flp-In HEK293 
cells (Invitrogen) were maintained in Dulbecco's 
Modified Eagle's Medium (DMEM) containing 
glucose (4.5 g/l), L-glutamine, 1% 
penicillin/streptomycin and supplemented with 
10% FBS. For stable clone generation, the 
wild-type (WT), LRP6 mutants in the 
pcDNA5/FRT expression vector were 
transfected into Flp-In HEK293 cells using the 
Fugene 6 transfection reagent (Roche). After 
48 h, cells were split into a 15cm2 dish. After 
cells attached to the dish, fresh medium with 
hygromycin B (100µg/ml) was used to select 
resistant cells in which the cDNA construct had 
been integrated into the Flp-In site. The cells 
were fed with selection medium every 5 days 
until colonies could be identified. 10-15 
individual stable clones for LRP6 WT and each 
mutant were picked and amplified for further 
characterization. Pitstop 2 was obtained from 
Abcam. Human Cav-1 siRNA was purchased 
from Dharmacon. To isolate lipid raft associated 
proteins, FOCUS-Global Protein Fractionation 
kit (G-Biosciences) was used according to the 
manufacturer’s instructions. 
    Flow cytometry - Cells were detached by 
non-enzymatic cell dissociation solution (Sigma). 
For total LRP6 analysis, cells were treated with 
0.1% saponin in PBS for 30 min prior to 
incubation with antibody. For cell surface LRP6, 
cells were incubated with primary antibody 
without permeabilization. Successive incubation 
with anti-HA IgG (30 µg/ml) for HA-LRP6 and 
anti-mouse Alexa Fluor 488 (Molecular Probes) 
were carried out at 4°C for 1 h. As a control, 
background fluorescence intensity was assessed 
in the absence of the primary antibody. All 
measurements were performed on a 
FACSCalibur (BD Biosciences). Histograms 
were generated using the CellQuest software and 
the mean values, after subtraction of controls, 
were compared among samples.  
     Determination of LRP6 half-life - Cells 
were incubated with cycloheximide (CHX 
100 µg/ml, Sigma) to inhibit protein synthesis. 
Following incubation for 0, 0.5, 1, 2, 4 or 8 hrs, 
cells were lysed and subjected to Western blot.  
    Antibody uptake and immunofluorescent 
staining - Anti-HA IgG was labeled using Alexa 
Fluor 488 Protein Labeling Kit (Molecular 
Probes). Cells were cultured on the 
Poly-D-Lysine-coated glass bottom culture 
dishes (MatTek Corp.) at 37°C for at least 24 h 
before experiments. Cells were incubated with 
Alexa 488-HA IgG for 1 h at 4°C and shifted to 
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internalization. After incubation at 37°C, cells 
were fixed with 4% paraformaldehyde (PFA) for 
20 min. For immunofluorescence staining, cells 
were washed with PBS and fixed with 4% PFA 
in PBS for 20 min at room temperature. Cells 
were then blocked with blocking buffer (PBS 
containing 0.5% BSA) and permeabilized with 
PBS containing 0.2% Triton X-100. Afterward, 
the cells were incubated with primary LRP6 or 
EEA1 antibodies for 2 h at room temperature, 
followed by an Alexa Fluor-conjugated 
secondary antibody for 1 h (Molecular Probes). 
The cell surface LRP6 was stained without 
permeabilization. Stained cells were viewed by 
confocal laser-scanning fluorescence 
microscopy (model LSM 510 invert; Carl Zeiss). 
To quantify the levels of cell surface LRP6, 
10-12 fields per WT or mutant samples were 
chosen and the fluorescent intensity was 
measured by Image J. 
    Kinetic analysis of endocytosis - Kinetic 
analysis of receptor-mediated endocytosis was 
carried out as described previously (26). Briefly, 
cells were cultured in Poly-D-Lysine coated 
12-well plates 24 h before experiments. Cells 
were rinsed twice with cold PBS and then 
incubated in 0.5 ml of ice-cold ligand binding 
buffer (DMEM containing 0.6% bovine serum 
albumin) containing 1 nM 125I-Mesd for 1 h. 
After binding, pre-warmed binding buffer was 
added to the cells and the plates were placed in a 
37°C water bath for 0, 5, 10, 20, 30, 60 min to 
initiate internalization. The plates were then 
placed on ice, and the ligand binding buffer was 
replaced with ice-cold stop/strip solution (PBS, 
pH 2.0). Ligands that remained on the cell 
surface was stripped twice by incubating cell 
monolayers with ice-cold stop/strip solution for 
a total of 10 min and counted. Cell monolayers 
were then solubilized with low-SDS lysis buffer 
(6.25 mM Tris pH 6.8, 0.2% SDS, 10% glycerol, 
and bromophenol blue) to release internalized 
radioactivity. The sum of internalized ligands 
plus those on the surface after each assay was 
used as the maximum potential internalization. 
The fraction of internalized ligand at each time 
point was calculated and plotted. 
Co-immunoprecipitation - Cells were lysed 
and the lysates were precleared for at least 2 h 
with Protein-A agarose beads and then incubated 
with an antibody overnight at 4oC. The 
immunocomplexes were precipitated with 
Protein-A agarose beads for 1 h, washed 3 times 
with PBS, and boiled in SDS sample buffer 
containing β-mercaptoethanol. The supernatants 
were subjected to SDS-PAGE and Western 
blotting. 
Immunoblotting - Cells were lysed in PBS 
containing 1% Triton, protease inhibitor cocktail 
(Roche), and 1 mM PMSF at 4°C for 30 minutes. 
Equal quantities of protein were subjected to 
7.5%, 12.5% or 4-15% SDS-PAGE and 
transferred to immobilon-P membrane 
(Millipore).  Membranes were blocked in PBS 
5% non-fat dried milk with 0.05% Tween 20 and 
subjected to incubation with primary and 
secondary antibodies. Membrane probed with 
horseradish peroxidase-conjugated secondary 
antibody (Amersham Pharmacia) was visualized 
by ECL detection system (Pierce) and exposed 
to film. The gel image was scanned by 
ChemiDoc imaging system (Bio-Rad) and 
quantified. In some experiments, membrane was 
probed with LI-COR IRDye secondary 
antibodies and detected using the Odyssey 
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following antibodies were used in this study: 
LRP6, phospho-LRP6 (Ser1490), procaspase-3 
and cleaved caspase-3 antibodies (Cell 
signaling), β-catenin antibody (BD Pharmingen, 
Cell signaling), Transferrin Receptor 
(Invitrogen), Caveolin-1 (Santa Cruz), actin and 
Clathrin antibodies (Sigma). 
    Fractionation of Plasma Membrane - Cells 
expressing WT and mutant LRP6 were lysed in 
0.25 ml of ice-cold TNE buffer containing 0.4% 
Triton X-100, 1mM PMSF, cocktail protease 
inhibitor and phosphatase inhibitors. Cells were 
then homogenized with a Dounce homogenizer 
(40 strokes) and passaged through a 25 gauge 
needle. Each lysate (0.25 ml) was mixed with 
0.25 ml of 80% (w/v) sucrose in TNE and 
overlaid with 1 ml of 35% sucrose in TNE, 
followed by 0.5 ml of 5% sucrose in TNE. The 
gradients were centrifuged at 54,000 rpm for 16 
h at 4°C in a TLS55 rotor (Beckman, USA).  
120 µL fractions were harvested from the top of 
the gradient. Aliquots were subjected to 
SDS-PAGE and probed with the indicated 
antibodies.  
    Quantitative Real-Time PCR - Total RNAs 
isolated from Flp-In HEK293 cells expressing 
WT or mutant LRP6 using Trizol (Invitrogen) 
and RNeasy Mini Kit (Qiagen) were 
reverse-transcribed with Superscript First-Strand 
Synthesis System (Invitrogen). The reaction mix 
was subjected to quantitative real-time PCR 
(qRT-PCR) to detect expression levels of LRP6. 
All primers for real-time PCR were ordered 
from SABiosciences. Triplicate reactions were 
prepared using a 25-µl mixture containing 
Platinum SYBR Green qPCR Super Mix UDG 
(Invitrogen). Real-time quantification was 
performed on a Bio-Rad iCycle iQ system. All 
data were normalized to the endogenous actin 
expression.  
    GST-E-cadherin Pull-down Assay - The 
assay was carried out as described previously 
(27). Cells were lysed for 30 minutes at 4°C. 
Protein concentrations in lysates were quantified, 
and equal quantities of total proteins from 
different samples were incubated with 
GST-E-cadherin Sepharose beads for 4 h at 4°C. 
After incubation, the beads were washed three 
times and the bound proteins were eluted and 
separated via SDS-PAGE. Western blotting was 
performed using antibody to β-catenin. 
Luciferase Reporter Assay - Cells were 
transfected with TOPFlash or FOPFlash 
plasmids (Upstate) and treated with conditioned 
media from parental L cell or Wnt3a-expressing 
cultures for 24 h. A β-gal reporter cDNA was 
co-transfected to normalize data for transfection 
efficiency. The luciferase and β-gal activities 
were measured by the Luciferase and β-gal 
Assay Systems, respectively, following the 
manufacturer’s instructions (Promega).  
    Statistical Analysis - All quantified data 
represent an average of triplicate samples. Error 
bars represent standard deviation (SD). 
Statistical analyses were performed using 
Student's t-test when one group was compared 
with the control group. When more than two 
groups were compared, analysis of variance 
(ANOVA) with Bonferroni multiple comparison 
post hoc test was used to determine the 
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- Receptor-mediated endocytosis is driven by 
signals within the intracellular domains of cell 
surface receptors. The LRP6 cytoplasmic tail 
contains two such tyrosine-based signals: YXXY 
and YXXF motifs (Fig. 1A). To examine their 
roles in LRP6 endocytosis, we mutated both 
motifs from “YRPYSYRHF” to “ARPASARHA” 
(hereafter referred to as tyrosine mutant). In 
addition, given that Wnt stimulates LRP6 
phosphorylation on the PPPS/TP motif, which is 
critical for Axin binding and its signaling 
activity (10), we sought to examine whether 
LRP6 phosphorylation plays a role in regulating 
its endocytosis. As such, we mutated the critical 
Ser/Thr residues within all five PPPS/TP 
signaling motifs to Ala (hereafter referred to as 
serine/threonine mutant) (Fig. 1A). 
  Because variation in transfection efficiency 
among different LRP6 mutant constructs and 
heterogeneous expression within a given cell 
population might result in experimental 
variability, we used the Flp-In system to 
establish stable HEK293 cell lines in which a 
single copy of wild-type LRP6 (hereafter 
referred to as WT) or either of the mutants was 
introduced into a defined chromatin location. 
Using real-time PCR (Fig. 1B) and Western blot 
analysis (Fig. 1C), HEK293 stable clones 
exhibiting similar levels of WT or mutant LRP6 
were selected for the study. 
    To investigate the role of specific motifs in 
LRP6 endocytosis, we first examined the cell 
surface distribution of WT and mutant LRP6 by 
FACS analysis. In cells expressing the LRP6 
tyrosine mutant, the amount of cell surface 
LRP6 was significantly increased compared to 
cells expressing LRP6 WT; however, in cells 
expressing the serine/threonine mutant, there 
was no increase in LRP6 cell surface levels (Fig. 
1D). To further confirm this result, we 
performed a cell surface biotinylation analysis to 
quantify the cell surface level of LRP6. 
Cell-surface proteins were labeled with 
sulfo-NHS-LC-biotin, isolated with streptavidin 
beads and probed with anti-LRP6 antibody. 
Consistent with results from FACS analysis, we 
found that the cell surface level of LRP6 was 
significantly increased in cells expressing the 
LRP6 tyrosine mutant (Fig. 1E). The 
immunofluorescence staining of LRP6 also 
revealed that the tyrosine mutant exhibited an 
increased cell surface staining of LRP6 
compared to WT under non-permeabilized 
condition (Fig. 1, F and G). Under 
permeabilized conditions, LRP6 WT was mostly 
distributed in the endosomal compartments and 
partially co-localized with EEA1, a marker for 
early endosome.  Importantly, a significant 
increase in the cell surface distribution of LRP6 
tyrosine mutant compared to LRP6 WT was 
observed with little co-localization with EEA1 
(Fig. 1H). Together, these results suggest that 
disruption of tyrosine-based motifs of LRP6, but 
not the phosphorylation motifs, impair its 
internalization and result in an increase in its cell 
surface distribution. 
    To further study whether tyrosine-based 
motifs of LRP6 serve as an endocytotic signal, 
we next monitored LRP6 endocytosis by 
pulse-chase analysis. Cells expressing 
HA-tagged LRP6 WT or tyrosine mutant were 
first incubated with fluorescent-labeled HA 
antibody at 4°C, which labels LRP6 at the 
plasma membrane (Fig. 2A). Upon warming up 
to 37°C, a substantial amount of LRP6 was 
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significant endocytosis seen after 15-30 min. On 
the other hand, LRP6 was retained mostly at the 
cell surface even after 60 min incubation in cells 
expressing tyrosine mutant (Fig. 2A). 
    To directly measure endocytosis rates of 
LRP6 WT and mutants, 125I-labeled Mesd, a 
specialized chaperone and a ligand for LRP6 
(28,29), was utilized to perform the endocytosis 
assay. The fraction of internalized ligand after 
each time point was calculated and plotted (Fig. 
2B). The half-time (t1/2) for the internalization of 
LRP6 WT and the serine/threonine mutant was 
determined to be 4.85±0.73 min and 5.02±0.42  
min, respectively, while LRP6 tyrosine mutant 
exhibited a much slower endocytosis rate with a 
t1/2 of 10.22±0.27 min (Fig. 2B). These results 
further indicate that tyrosine-based motifs might 
serve as an endocytotic signal within the LRP6 
cytoplasmic tail. In addition, we found that the 
LRP6 tyrosine mutant exhibited a longer 
half-life compared to that of LRP6 WT when 
cycloheximide was used to block protein 
synthesis (Fig. 2C). The t1/2 for LRP6 WT was 
3.68 h and the t1/2 for tyrosine mutant was 7.07 h, 
indicating that impairment of LRP6 
internalization prolonged its half-life.   
     Redistribution of LRP6 Endocytosis 
Mutant to Caveolae Enhances its 
Phosphorylation and Wnt/β-catenin Signaling – 
To determine whether inhibition of endocytosis 
or phosphorylation of LRP6 alters its 
internalization route in the presence or absence 
of Wnt3a stimulation, lysates of cells expressing 
LRP6 WT or mutants were subjected to 
fractionation by sucrose gradient. Of note, the 
LRP6 tyrosine mutant showed increased 
distribution of LRP6 in lipid rafts compared with 
LRP6 WT (Fig. 3, A-C). These results suggest 
that inhibition of LRP6 internalization through 
the clathrin-mediated pathway redistribute LRP6 
to raft fractions. In addition, Wnt3a 
administration also increased LRP6 distribution 
in the lipid raft fractions (Fig. 3, A and B). To 
further validate this observation, we isolated 
lipid raft-associated membrane proteins from 
cells expressing LRP6 WT or mutants. 
Consistent with our previous findings, we found 
that mutation of tyrosine-based motifs enhanced 
LRP6 distribution in lipid rafts in the absence of 
Wnt3a stimulation (Fig. 3, D and E). To 
investigate whether disruption of LRP6 
phosphorylation or internalization affects its 
association with caveolin, we examined their 
interactions in the presence or absence of Wnt3a 
ligand by co-immunoprecipitation analysis. 
While Wnt3a stimulation significantly increased 
the association of LRP6 WT with caveolin (Fig. 
3F), the LRP6 tyrosine mutant exhibited a 
stronger association with caveolin compared to 
WT even in the absence of Wnt stimulation (Fig. 
3F). These results indicate that tyrosine-based 
signals play an important role in determining 
LRP6 internalization routes as well as serve as 
an endocytosis motif. 
A crucial step in Wnt/β-catenin signaling 
activation is the phosphorylation of PPPS/TP 
motifs in the intracellular domain of LRP6 via 
Casein kinase 1γ (CK1γ) and GSK3β. The 
phosphorylation of LRP6 stabilizes the 
Wnt/β-catenin signaling transducer β-catenin 
resulting in signaling activation (10). To 
investigate whether disruption of 
clathrin-mediated endocytosis of LRP6 affects 
its phosphorylation and Wnt/β-catenin signaling 
activation, we assessed the phosphorylation 
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analysis and the strength of Wnt/β-catenin 
signaling by TCF reporter analysis. As expected, 
Wnt3a significantly induced Wnt/β-catenin 
signaling activation in both LRP6 WT and 
tyrosine mutant, while the serine/threonine 
mutant was not phosphorylated and exhibited 
minimal signaling activation (Fig. 4, A-C). 
Interestingly, LRP6 tyrosine mutant is 
phosphorylated to a greater degree in the 
absence of Wnt3a treatment (Fig. 4A), while 
displaying a reduced basal level of Wnt 
signaling compared to WT (Fig. 4, D and E). In 
addition, Wnt3a stimulation induced a greater 
activation of Wnt/β-catenin in cells expressing 
LRP6 tyrosine mutant compared with WT (Fig. 
4, D and E). Taken together, these results 
suggest that lipid raft distribution of LRP6 led to 
an increase in its phosphorylation; however, it is 
not sufficient to induce Wnt/β-catenin signaling 
activation in the absence of Wnt ligands.  
     Blocking of Caveolae-mediated, but not 
Clathrin-mediated Endocytosis Reduces LRP6 
Phosphorylation and Wnt/β-catenin Signaling - 
To examine whether alteration of LRP6 
internalization routes affects its phosphorylation 
and signal transduction, cells expressing WT or 
LRP6 mutants were treated with nystatin (Nys) 
or monodansylcadaverine (MDC), inhibitors for 
caveolae or clathrin-mediated endocytosis, 
respectively. We found that Nys significantly 
inhibited LRP6 phosphorylation both in the 
presence and absence of Wnt3a stimulation, 
whereas inhibition of clathrin-mediated 
endocytosis via MDC had no significant effect 
(Fig. 5A). We also examined which 
internalization route is important for Wnt3a 
signaling activation. Blocking 
caveolin-mediated endocytosis by Nys 
suppressed Wnt signaling (Fig. 5B). 
Furthermore, cells expressing LRP6 tyrosine 
mutant exhibit higher Wnt signaling activation 
which is suppressed by Nys treatment (Fig. 5B). 
As phosphorylation of LRP6 is required for 
signaling activation, we tested whether 
knockdown of caveolin-1 by small interfering 
RNA (siRNA) affects LRP6 phosphorylation 
(Fig. 5C). Consistent with the effects via Nys 
treatment, knockdown of caveolin-1 suppressed 
LRP6 phosphorylation (Fig. 5, D and E). 
Interestingly, inhibition of clathrin-mediated 
endocytosis via MDC, or Pitstop 2, a more 
selective clathrin inhibitor, slightly increased 
basal level of signaling in the absence of Wnt3a 
treatment (Fig. 5, F and G), whereas MDC has 
no significant effect in the presence of Wnt3a 
(Fig. 5F). Together, these results indicate that 
caveolin-mediated endocytosis of LRP6 is 
critical for Wnt3a-induced signaling activation.  
 
DISCUSSION 
    The Wnt/β-catenin signaling pathway 
controls a myriad of biological phenomena 
throughout development and in adulthood. 
Aberrant activation of this pathway underlies the 
pathogenesis of several human diseases (30). 
Thus, it is critical to understand how 
Wnt/β-catenin signaling is regulated under 
physiological condition in order to develop 
better therapeutic methods against diseases 
resulting from misregulation of this pathway.  
    Given the critical role of Wnt signaling 
cascade, intricate control systems have evolved 
to regulate its function. Wnt/β-catenin signaling 
is tightly modulated by secreted ligands or 
antagonists that bind to LRP6 at the cell surface 
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Dickkopf1 (Dkk1) is a well-known potent 
antagonist of this signaling pathway (31,32). 
Previous study shows that Dkk1 has high 
affinity for LRP6 and inhibits Wnt/β-catenin 
signaling through binding to Kreman (Krm), a 
single-transmembrane protein (33,34). The 
resultant Dkk1/LRP6/Krm complex removes 
LRP6 from the membrane via endocytosis and 
thereby attenuating Wnt/β-catenin signaling 
activation (35). The transmembrane and 
cytoplasmic domains of Krm are not required for 
triggering LRP6 endocytosis, suggesting that the 
functional endocytosis signal might reside 
within the LRP6 tail.  
    In the current study, we showed that the 
LRP6 mutant with defective tyrosine-based 
motifs exhibited increased cell surface 
distribution, a slower endocytosis rate and a 
longer half-life compared to wild-type LRP6. In 
addition, disruption of tyrosine-based motifs 
within the LRP6 tail increased its distribution on 
the lipid raft and its association with caveolin.    
Caveolin mediates clathrin-independent 
endocytosis through membrane invaginations on 
lipid raft forming caveolae (20). The uptake 
kinetics of caveolae-mediated endocytosis is 
much slower than that of clathrin-mediated (36), 
which is the pathway necessary for LRP6 
degradation (37). As a result, the altered 
distribution of LRP6 tyrosine mutant on the lipid 
raft is likely the cause of its slower endocytosis 
rate and a longer half-life. Mounting studies 
show that distinct internalization routes and 
molecular machineries are utilized for either 
receptor degradation or signaling. The 
clathrin-mediated pathway plays a crucial role in 
terminating cell signaling by down-regulating 
transmembrane signaling receptors. For example, 
activated growth factor-induced epidermal 
growth factor receptors (EGFRs) are internalized 
and transported via endosomes to lysosomes for 
degradation in the presence of low-level EGF, 
thus preventing the overgrowth of the cell 
(14,15). On the other hand, EGFR receptors 
have been shown to be degraded in the lipid raft 
route and to be signaling in the 
clathrin-mediated route when the EGF level is 
high (16,17). In the case of TGF-β signaling, 
both pathways play a role (18) depending on its 
adaptor protein Sara or Rap2. In these cases, the 
clathrin pathway is thought to direct receptors to 
a recycling pathway, thus protecting the 
receptors from degradation and supporting 
sustained signaling. Our results clearly showed 
that the LRP6 receptor utilizes an alternative 
mechanism in which the caveolae-dependent 
pathway promotes Wnt/β-catenin signaling 
transduction and the clathrin route mediates its 
degradation. Although it is unclear whether 
translocation of LRP6 to the lipid raft is a 
passive event, the disruption of tyrosine-based 
motifs in the LRP6 cytoplasmic tail may 
enhance its self-aggregation or association with 
lipid-raft-resident proteins.  
    We also found that LRP6 levels were 
increased in the lipid raft microdomain after 
Wnt3a stimulation. Wnt3a treatment has been 
suggested to induce LRP6 aggregation at the 
plasma membrane, and the clustering of LRP6 
provides a high local receptor concentration that 
may trigger LRP6 phosphorylation by CK1γ (9). 
It is possible that Wnt3a induces LRP6 
oligomerization, which increases its affinity to 
lipid rafts where LRP6 can be phosphorylated 
and activated. Consistent with this notion, Fz5 
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Wnt/β-catenin pathway, is internalized in a 
clathrin-dependent manner when it is expressed 
without LRP6 and Wnt, whereas the 
Wnt3a-Fz5-LRP6 complex is internalized 
through the caveolin-mediated pathway in 
response to Wnt3a (38). Interestingly, the LRP6 
tyrosine mutant exhibited stronger 
phosphorylation and signaling activation in 
response to Wnt3a ligands and these effects 
were suppressed by the caveolae inhibitor, 
nystatin. These findings indicate that caveolae 
serves as a site for initiating ligand-induced 
LRP6 internalization. Acting as a signaling 
platform, this dynamic regulation could facilitate 
the integration of signaling molecules, thus 
ensuring specificity and efficiency in the signal 
transduction processes (39).  
    There are conflicting data on the 
internalization pathways of LRP6 and their roles 
in the activation of Wnt/β-catenin signaling. One 
study showed that Wnt3a induces the 
internalization of LRP6 through the 
clathrin-mediated pathway, leading to the 
accumulation of β-catenin (40). In contrast, 
another study suggested that internalization of 
LRP6 through caveolin, rather than clathrin, is 
necessary for the Wnt3a-dependent 
accumulation of β-catenin (38). Furthermore, it 
has been shown that Wnt3a promotes 
caveolae-mediated internalization of LRP6, 
while Dkk1 induces the internalization of LRP6 
in a clathrin-dependent manner (37). A recent 
finding showed that the endocytic adaptor 
disabled-2 (Dab2), which inhibits Wnt/β-catenin 
signaling shunts LRP6 towards the 
clathrin-dependent endocytic route (41). 
Although further experiments are necessary to 
confirm the relationship among Wnt/β-catenin 
signaling and the LRP6 endocytosis pathway, 
these events are likely regulated by the amount 
and subtype of Wnt ligands and/or the presence 
of adapter molecules. 
     Previous studies addressing the 
relationship between LRP6 endocytosis and 
signaling by exclusively using pharmacological 
inhibitors and siRNA approaches likely have 
potential caveats. These approaches perturb the 
entire clathrin or caveolae pathway, which could 
lead to non-specific and/or indirect effects. It is 
possible that irrelevant receptors or pathways 
that rely on these internalization mechanisms 
might be altered, affecting LRP6 endocytosis 
and trafficking. Using LRP6 endocytosis 
mutants, herein we investigated the mechanism 
underlying LRP6 endocytosis, trafficking and 
signaling without disturbing the endocytic 
pathways.  
      In summary, we demonstrate that 
tyrosine-based motifs within the LRP6 tail serve 
as an endocytosis signal that determines LRP6 
internalization routes (Fig. 6). LRP6 is 
internalized by a mechanism involving both the 
clathrin- and caveolin-mediated pathways. 
Because Wnt ligands are associated with lipid 
raft due to their palmitoylation modification (42), 
the bindings of Wnts to LRP6 and Fz 
co-receptors promote their translocation to lipid 
rafts, where LRP6 might be more likely to 
accumulate and form “signalosomes” (9). 
Aggregated LRP6 is phosphorylated in this 
specialized microdomain and internalized in a 
caveolin-dependent manner, which activates 
Wnt/β-catenin signaling. When 
clathrin-mediated endocytosis of LRP6 is 
blocked due to defective endocytosis motifs, 
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increase of lipid raft partition of LRP6 leads to 
an enhanced phosphorylation of the receptor and 
Wnt/β-catenin signaling activation in tyrosine 
mutant. Our results shed light on the molecular 
mechanisms underlying LRP6 endocytosis and 
signaling and how the dynamic distribution of 
LRP6 between the clathrin and caveolin 
pathways plays a crucial role in regulating 
Wnt/β-catenin signaling. Taken together, 
understanding the dynamic regulation and 
pathological roles of LRP6 in Wnt signaling 
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FIGURE 1. LRP6 tyrosine mutant displays increased cell surface distribution. A, A schematic 
diagram of potential endocytosis motifs in the LRP6 cytoplasmic tail. The LRP6 tail contains 
tyrosine-based motifs (Yellow) and five highly conserved PPPS/TP motifs in which the Ser/Thr residues 
can be phosphorylated (Blue). B, LRP6 mRNA expression in HEK293 cells stably expressing LRP6 WT 
or mutants was analyzed by real-time PCR. Ymt, tyrosine mutant; Smt, serine/threonine mutant. C, LRP6 
expression in these cells was analyzed by Western blot and quantified. D, Cells stably expressing LRP6 
WT or mutants were labeled with anti-HA antibody, and the levels of cell surface and total cellular LRP6 
were assessed by flow cytometry. E, The cell surface levels of LRP6 were quantified by cell surface 
biotinylation assay. Cell surface proteins from cells stably expressing LRP6 WT or tyrosine mutant were 
biotinylated, isolated with avidin-conjugated beads, and immunoblotted with HA antibody against LRP6. 
Cell surface and total LRP6 in cell lysates was measured by Western blot. F, G, Cells stably expressing 
LRP6 WT or mutants were fixed without permeabilization, and stained for LRP6 with anti-HA (green) 
and the nucleus with DAPI (blue). Scale bars, 5 µm. Fluorescence measurements for LRP6 were 
performed with Image J (G). H, Cells stably expressing LRP6 WT or tyrosine mutant were fixed, 
permeabilized, and stained for LRP6 with anti-HA (green) and co-stained with anti-EEA1 (red). 
Representative confocal laser scanning microscopy images were shown. Scale bars, 5 µm. Data are 
representative of three independent experiments. Data represent mean ± SD. N.S., not significant; *, p < 
0.05. **, p < 0.01.  
 
FIGURE 2. Mutation of tyrosine-based motifs in the LRP6 cytoplasmic tail impairs its endocytosis. 
A, HEK293 cells stably expressing the LRP6 WT or tyrosine mutant were incubated with 
Alexa488-labeled anti-HA IgG for 1 h at 4°C, and then shifted to 37°C for increasing periods of time to 
initiate endocytosis. Fluorescence images were obtained by confocal microscopy. Scale bars, 5 µm. B, 
Cells stably expressing LRP6 WT, tyrosine and serine/threonine mutants were subjected to a kinetic 
analysis of endocytosis using 125I-labeled Mesd (5 nM). The sum of ligand that was internalized, plus that 
which remained on the cell surface at the end of the assay was used as the maximum potential 
internalization. The fraction of internalized ligand after each time point was calculated and plotted (B, left 
panel). Data represent mean ± SD. Then, Ln [Vmax (maximum internalization) - Vt (internalization % at 
each time point)] was calculated and plotted against each time point (B, middle panel). The half-time (t1/2) 
for the internalization of LRP6 was then calculated as t1/2 = ln2/k = 0.693/(slope) and is shown as bar 
graph (B, right panel). Data represent mean ± SD. **, p < 0.01. Ymt, tyrosine mutant; Smt, 
serine/threonine mutant. C, Cells stably expressing LRP6 WT or tyrosine mutant were treated with 
cycloheximide and lysed at 0, 0.5, 1, 2, 4 and 8 h following the treatment. Lysates were then 
immunoblotted for LRP6. The half-life of LRP6 was calculated on the basis of the slope of the semilog 
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FIGURE 3. Distribution of LRP6 with defective tyrosine-based motifs in lipid rafts. A, Lysates of 
cells expressing WT and LRP6 mutants treated with control conditioned medium (CM) or Wnt3a CM 
were fractionated by sucrose density gradient centrifugation and probed with anti-LRP6 antibody. 
Endogenous caveolin-1 (Cav1) and clathrin (Cla), which indicate the respective positions of lipid rafts 
and non-lipid raft factions, respectively, were detected using specific antibodies. Ymt, tyrosine mutant; 
Smt, serine/threonine mutant. B, Densitometric quantification of Western blot signals from (A). The LRP6 
intensities in all fractions were added up as total signals. The percentage of LRP6 levels in the lipid raft 
enriched fractions (fractions 2-8) and non-lipid raft fractions was calculated and shown. C, The LRP6 
levels in each fraction is plotted as “% total signal”. D, Cells expressing WT and LRP6 mutants were 
treated with control conditioned medium (CM) or Wnt3a CM for 16 h. The membrane proteins 
concentrated in caveolin-rich membranes and lipid rafts were isolated and subjected to Western blot 
analysis. E, Densitometric quantification of Western blot signals from (D). N.S., not significant; *, p < 
0.05; **, p < 0.01. F, Co-immunoprecipitation of LRP6 and caveolin-1. Lysates of cells expressing WT 
and LRP6 mutants were immunoprecipitated with anti-caveolin-1 (Cav1) and the immunoprecipitates 
were probed with anti-LRP6 antibody. Data represent mean ± SD. *, p < 0.05.  
 
FIGURE 4. Enhanced phosphorylation and Wnt/β-catenin signaling activation of LRP6 with 
defective tyrosine-based motifs. A, Lysates of cells expressing WT or LRP6 mutants were subjected to 
Western blot analysis and probed with anti-LRP6 or anti-phospho-LRP6 (Ser1490) antibodies. Ymt, 
tyrosine mutant; Smt, serine/threonine mutant. B, the ratios of phospho-LRP6 (p-LRP6) versus total 
LRP6 were compared between WT and tyrosine mutant. C-E, Cells expressing WT or mutant LRP6 were 
transfected with TOPflash/FOPflash plasmids and were subsequently incubated with control CM or 
Wnt3a CM for 16 h. Wnt/β-catenin signaling activity was evaluated with TOPflash TCF-luciferase 
reporter (C, E) or GST-E-cadherin pull-down assays (D). To clearly illustrate the signal activation in the 
presence or absence of Wnt3a stimulation, the activities were plotted together (C) or separately (E). Data 
are representative of three independent experiments. Data represent mean ± SD. N.S., not significant; **, 
p < 0.01. 
 
FIGURE 5. Inhibition of caveolae-mediated endocytosis suppresses LRP6 phosphorylation and 
Wnt/β-catenin signaling activation. A, Cells expressing LRP6 WT or mutants were pre-treated with or 
without nystatin (Nys) or monodansylcadaverine (MDC) for 1 h prior to addition of control CM or Wnt3a 
CM for additional 2 h. LRP6 phosphorylation was examined by anti-phospho-LRP6 (Ser1490) antibody. 
Ymt, tyrosine mutant; Smt, serine/threonine mutant. B, Cells expressing WT or LRP6 mutants were 
pre-treated with or without Nys for 1 h prior to incubation with control CM or Wnt3a CM for 2 h. 
Wnt/β-catenin signaling activity was evaluated with TOPflash TCF-luciferase reporter assay. Data are 
representative of three independent experiments. Data represent mean ± SD. N.S., not significant; *, p < 
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of Cav1 and β-actin were examined by Western blot analysis. D, E, Cells expressing LRP6 WT or mutants 
were transfected with control or Cav 1 siRNA for 48 h. LRP6 phosphorylation was examined by Western 
blot analysis (D) and quantified (E). F, Cells expressing WT or LRP6 mutants were pre-treated with or 
without MDC for 1 h prior to incubation with control CM or Wnt3a CM for 2 h. Wnt/β-catenin signaling 
activity was evaluated with TOPflash TCF-luciferase reporter assay. G, Cells expressing LRP6 WT or 
mutants were treated with 25 µM Pitstop 2, a selective clathrin inhibitor, for 15 min at 37°C, and the level 
of LRP6 phosphorylation was examined by Western blot analysis. 
 
FIGURE 6. Possible mechanism of LRP6 endocytosis and phosphorylation and their relationship to 
Wnt/β-catenin signaling activation. A, In the absence of Wnt ligands, LRP6 is partitioned between lipid 
raft and non-lipid raft domains at the plasma membrane, which maintains basal levels of Wnt/β-catenin 
signaling. B, The binding of Wnts to LRP6 and Fz co-receptors promote their translocation to lipid rafts, 
where LRP6 is accumulated, phosphorylated and internalized in a caveolin-dependent manner, which 
enhances Wnt/β-catenin signaling. C, D, When clathrin-mediated endocytosis of LRP6 is blocked due to 
defective endocytosis motifs, LRP6 is distributed mostly in the lipid raft domains. This increase of lipid 
raft partition of LRP6 leads to further enhanced phosphorylation of the receptor and Wnt/β-catenin 
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